LAKSHMI CHINTHALA: Open Payments
NPI 1689132862 · AUSTIN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,885 in 17 payments from 14 companies in 2025. Trend: 2023 $68 · 2024 $1,599 · 2025 $1,885
Food & beverage: $1,885
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 2 | $291 |
| ViiV Healthcare Company | 2 | $228 |
| Neurocrine BioSciences, Inc. | 1 | $151 |
| Averitas Pharma Inc. | 2 | $150 |
| ABIOMED | 1 | $137 |
| Phathom Pharmaceuticals, Inc. | 1 | $127 |
| ABBVIE INC. | 1 | $122 |
| Amgen Inc. | 1 | $116 |
| Sandoz Inc. | 1 | $112 |
| Regeneron Healthcare Solutions, Inc. | 1 | $105 |
Products named: APRETUDE, INGREZZA, Livdelzi, QUTENZA, Yeztugo, VOQUEZNA, MAVYRET, OTEZLA.
Industry payments across TX — which companies pay providers there.
